Our DPUK team from AAIC 24 is regrouping now after a very busy week covering lots of ground. We asked a few of them to tell us their personal highlights and share the big news stories to emerge.
Research into the life-shortening neurological condition motor neurone disease (MND) will receive a major boost through the formation of a new data catalyst led by Dementias Platform UK (DPUK) and Health Data Research UK (HDR UK).
Dementias Platform UK recently welcomed the dementia research community to London for two days packed full of research updates, collaboration and networking at the Translation 2024 conference.
There is a huge focus right now around improving dementia diagnosis rates. Part of the work we\u2019re doing here at DPUK enables researchers to identify biomarkers which may be able to detect the risk of dementia earlier, confirmed by a simple blood test. This could be transformational in speeding up and improving the diagnostic process.
Our rapidly growing register of healthy volunteers, Great Minds, is holding its next live event on May 16th. The focus is on language, learning and music.
One of our speakers at Great Minds Live on May 16th in Sheffield (and for hundreds more online), is Professor Carol Holland. She has been studying ageing health psychology and frailty throughout her career. Carol is Director of the Centre for Ageing Research at Lancaster University and is currently President of the British Society of Gerontology.
The second day of #Translation2024 began with a personal account of living with mild cognitive impairment before we dived into the complexity of data and AI.
There has never been such a high level of focus on biomarkers as we have today. It's fitting that Translation 2024 began with a look into the exciting developments which are emerging from this wave of research.
Dementias Platform UK has been awarded over \u00a34 million to carry out countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve the UK\u2019s shocking diagnosis rate.
This week the DPUK executive team were thrilled to visit Downing Street to join a meeting focused on speeding up dementia research as part of the Dame Barbara Windsor Dementia Mission.
For our second year of Translation conference has a powerful programme of speakers. \r\nGathering on 18th-19th April in London, we're bringing together the dementia research community to focus on translational developments which are taking discoveries through in-human research to biomarkers, trials and into therapeutics.
The BBC's Panorama reports that there are challenges for the NHS in offering new dementia drugs Lecanemab and Donanemab. Accurate diagnosis is vital to determine who can benefit most from these Alzheimer's drugs. Two DPUK studies are assessing the feasibility of reliable diagnoses.
It is time to register for Translation 2024 - or risk missing out on our EARLYBIRD discount.\r\n\r\nThe conference programme for Translation 2024 is almost complete and soon we will be revealing the full programme and list of speakers. Watch this space for more very soon.
2023 has been a highly successful year for Dementias Platform UK. Our achievements are the result of work by our teams throughout the UK who have dedicated their time, research skills and resources to Dementias Platform UK.
Dementia Platform UK is organising the second Translation conference for 18-19 April 2024. We are working on the programme of speakers and will be announcing themes and speakers shortly. You can be the first to know by signing up for our conference and DPUK News Alerts.
![\"\"](\"https://www.dementiasplatform.uk/news-and-media/latest-news/dpuk-takeaways-from-aaic-2024/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n